Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Somatostatin receptor scintigraphy (SRS) is positive in approximately 75% of all patients with neuroendocrine gastroenteropancreatic tumours. This study aimed to identify specific somatostatin receptor (sstr) subtypes, which are responsible for the in vivo binding of the widely used somatostatin ana...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: John, M, Meyerhof, W, Richter, D, Waser, B, Schaer, J C, Scherübl, H, Boese-Landgraf, J, Neuhaus, P, Ziske, C, Mölling, K, Riecken, E O, Reubi, J C, Wiedenmann, B
Médium: Artigo
Jazyk:Inglês
Vydáno: 1996
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1382976/
https://ncbi.nlm.nih.gov/pubmed/8566856
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky